CN103816257A - Traditional Chinese medicine preparation for treating poliomyelitis - Google Patents
Traditional Chinese medicine preparation for treating poliomyelitis Download PDFInfo
- Publication number
- CN103816257A CN103816257A CN201410076263.0A CN201410076263A CN103816257A CN 103816257 A CN103816257 A CN 103816257A CN 201410076263 A CN201410076263 A CN 201410076263A CN 103816257 A CN103816257 A CN 103816257A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- poliomyelitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 208000000474 Poliomyelitis Diseases 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 241000722953 Akebia Species 0.000 claims abstract description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241000131808 Scolopendra Species 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 7
- 229940126701 oral medication Drugs 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 239000009490 scorpio Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241001481692 Mesobuthus martensii Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000006740 Aseptic Meningitis Diseases 0.000 description 1
- 206010027201 Meningitis aseptic Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation for treating poliomyelitis, which is prepared from the following bulk drugs in parts by weight: 15-25 parts of codonopsis pilosula, 10-20 parts of angelica sinensis, 10-20 parts of fructus liquidambaris, 10-20 parts of herba epimedii, 10-20 parts of morinda officinalis, 10-20 parts of eucommia ulmoides, 9-15 parts of radix puerariae, 9-15 parts of radix paeoniae alba, 6-12 parts of astragalus membranaceus, 6-12 parts of liquorice, 2-4 parts of Coptis chinensis, 2-4 parts of centipede, 2-4 parts of buthus martensi karsch, 15-25 parts of radix achyranthis bidentatae, 2-4 parts of cassia twig, 1-3 parts of akebia stem, and 6-12 parts of fructus chaenomelis lagenariae. The traditional Chinese medicine preparation has the advantages that the curative effect is remarkable, the traditional Chinese medicine preparation takes effect quickly, and toxic and side effects are avoided.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine preparation for the treatment of poliomyelitis.
Background technology
Poliomyelitis is poliomyelitis, is acute infectious disease, is caused by Virus entry blood circulation, and part virus can be invaded nervous system.Patient mostly is one to six years old child, and cardinal symptom is heating, general malaise, and limbs pain when serious, paralyses.Poliomyelitis is a kind of acute viral infectious disease, and its clinical manifestation is varied, comprises the non-specific pathological changes that degree is very light, and the relaxing property of aseptic meningitis and various muscle groups is unable.Poliomyelitis patient, because anterior horn motor neurons is impaired, relevant muscle has lost neural regulating action and atrophy has occurred with it, subcutaneous fat simultaneously, the also atrophy of tendon and skeleton, attenuates whole body.
At present, the medicine for the treatment of poliomyelitis is few, therefore invents a kind of medicine for the treatment of safely and effectively poliomyelitis very necessary.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine preparation for the treatment of poliomyelitis, that the present invention has advantages of is evident in efficacy, instant effect, have no side effect.
Treat a Chinese medicine preparation for poliomyelitis, made by the crude drug of following weight portion: Radix Codonopsis 15-25 part, Radix Angelicae Sinensis 10-20 part, Fructus Liquidambaris 10-20 part, Herba Epimedii 10-20 part, Radix Morindae Officinalis 10-20 part, Cortex Eucommiae 10-20 part, Radix Puerariae 9-15 part, Radix Paeoniae Alba 9-15 part, Radix Astragali 6-12 part, Radix Glycyrrhizae 6-12 part, Rhizoma Coptidis 2-4 part, Scolopendra 2-4 part, Scorpio 2-4 part, Radix Achyranthis Bidentatae 15-25 part, Ramulus Cinnamomi 2-4 part, Caulis Akebiae 1-3 part, Fructus Chaenomelis 6-12 part.
The Chinese medicine preparation of described treatment poliomyelitis, its preferably: the crude drug by following weight portion is made: 20 parts of Radix Codonopsis, 15 parts of Radix Angelicae Sinensis, 15 parts of Fructus Liquidambaris, 15 parts of Herba Epimedii, 15 parts of Radix Morindae Officinaliss, 15 parts of the Cortexs Eucommiae, 12 parts of Radix Puerariaes, 12 parts of the Radix Paeoniae Albas, 9 parts of the Radixs Astragali, 9 parts, Radix Glycyrrhizae, 3 parts of Rhizoma Coptidis, 3 parts of Scolopendras, 3 parts of Scorpios, 20 parts of Radix Achyranthis Bidentataes, 3 parts of Ramulus Cinnamomi, 2 parts of Caulis Akebiaes, 9 parts of Fructus Chaenomeliss.
The preparation method of the Chinese medicine preparation of described treatment poliomyelitis is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience instruct, and chooses each crude drug and proportioning thereof, has advantages of evident in efficacy, instant effect, has no side effect.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats polio victim's 38 examples altogether, wherein male 22 examples, female's 16 examples, the age is 1-8 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine preparation of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 10 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: symptom all disappears;
Take a turn for the better: symptom obviously alleviates;
Do not heal: symptom has no improvement.
(4) therapeutic outcome: the present invention treats polio victim's 38 examples altogether, through the treatment of 1-3 the course for the treatment of, cures 33 examples, accounts for 86.84%, and 4 examples that take a turn for the better, account for 10.53%, and effective percentage is 97.37%, has no any side effect; Cure in 33 examples, cure 16 examples 1 course for the treatment of, cure 10 examples 2 courses for the treatment of, cure 7 examples 3 courses for the treatment of; Result shows, that the present invention has advantages of is evident in efficacy, instant effect, have no side effect.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine preparation for poliomyelitis, made by the crude drug of following weight portion: 15 parts of Radix Codonopsis, 10 parts of Radix Angelicae Sinensis, 10 parts of Fructus Liquidambaris, 10 parts of Herba Epimedii, 10 parts of Radix Morindae Officinaliss, 10 parts of the Cortexs Eucommiae, 9 parts of Radix Puerariaes, 9 parts of the Radix Paeoniae Albas, 6 parts of the Radixs Astragali, 6 parts, Radix Glycyrrhizae, 2 parts of Rhizoma Coptidis, 2 parts of Scolopendras, 2 parts of Scorpios, 15 parts of Radix Achyranthis Bidentataes, 2 parts of Ramulus Cinnamomi, 1 part of Caulis Akebiae, 6 parts of Fructus Chaenomeliss.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine preparation for poliomyelitis, made by the crude drug of following weight portion: 20 parts of Radix Codonopsis, 15 parts of Radix Angelicae Sinensis, 15 parts of Fructus Liquidambaris, 15 parts of Herba Epimedii, 15 parts of Radix Morindae Officinaliss, 15 parts of the Cortexs Eucommiae, 12 parts of Radix Puerariaes, 12 parts of the Radix Paeoniae Albas, 9 parts of the Radixs Astragali, 9 parts, Radix Glycyrrhizae, 3 parts of Rhizoma Coptidis, 3 parts of Scolopendras, 3 parts of Scorpios, 20 parts of Radix Achyranthis Bidentataes, 3 parts of Ramulus Cinnamomi, 2 parts of Caulis Akebiaes, 9 parts of Fructus Chaenomeliss.Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine preparation for poliomyelitis, made by the crude drug of following weight portion: 25 parts of Radix Codonopsis, 20 parts of Radix Angelicae Sinensis, 20 parts of Fructus Liquidambaris, 20 parts of Herba Epimedii, 20 parts of Radix Morindae Officinaliss, 20 parts of the Cortexs Eucommiae, 15 parts of Radix Puerariaes, 15 parts of the Radix Paeoniae Albas, 12 parts of the Radixs Astragali, 12 parts, Radix Glycyrrhizae, 4 parts of Rhizoma Coptidis, 4 parts of Scolopendras, 4 parts of Scorpios, 25 parts of Radix Achyranthis Bidentataes, 4 parts of Ramulus Cinnamomi, 3 parts of Caulis Akebiaes, 12 parts of Fructus Chaenomeliss.Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (3)
1. a Chinese medicine preparation for the treatment of poliomyelitis, is characterized in that: the crude drug by following weight portion is made: Radix Codonopsis 15-25 part, Radix Angelicae Sinensis 10-20 part, Fructus Liquidambaris 10-20 part, Herba Epimedii 10-20 part, Radix Morindae Officinalis 10-20 part, Cortex Eucommiae 10-20 part, Radix Puerariae 9-15 part, Radix Paeoniae Alba 9-15 part, Radix Astragali 6-12 part, Radix Glycyrrhizae 6-12 part, Rhizoma Coptidis 2-4 part, Scolopendra 2-4 part, Scorpio 2-4 part, Radix Achyranthis Bidentatae 15-25 part, Ramulus Cinnamomi 2-4 part, Caulis Akebiae 1-3 part, Fructus Chaenomelis 6-12 part.
2. the Chinese medicine preparation for the treatment of poliomyelitis according to claim 1, is characterized in that: the crude drug by following weight portion is made: 20 parts of Radix Codonopsis, 15 parts of Radix Angelicae Sinensis, 15 parts of Fructus Liquidambaris, 15 parts of Herba Epimedii, 15 parts of Radix Morindae Officinaliss, 15 parts of the Cortexs Eucommiae, 12 parts of Radix Puerariaes, 12 parts of the Radix Paeoniae Albas, 9 parts of the Radixs Astragali, 9 parts, Radix Glycyrrhizae, 3 parts of Rhizoma Coptidis, 3 parts of Scolopendras, 3 parts of Scorpios, 20 parts of Radix Achyranthis Bidentataes, 3 parts of Ramulus Cinnamomi, 2 parts of Caulis Akebiaes, 9 parts of Fructus Chaenomeliss.
3. the preparation method of the Chinese medicine preparation for the treatment of poliomyelitis according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410076263.0A CN103816257B (en) | 2014-03-04 | 2014-03-04 | A kind of Chinese medicine preparation for the treatment of poliomyelitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410076263.0A CN103816257B (en) | 2014-03-04 | 2014-03-04 | A kind of Chinese medicine preparation for the treatment of poliomyelitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103816257A true CN103816257A (en) | 2014-05-28 |
| CN103816257B CN103816257B (en) | 2015-09-16 |
Family
ID=50751738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410076263.0A Expired - Fee Related CN103816257B (en) | 2014-03-04 | 2014-03-04 | A kind of Chinese medicine preparation for the treatment of poliomyelitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816257B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343458A (en) * | 2015-11-25 | 2016-02-24 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with syndrome of pathogen invading lung-defense phase |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086429A (en) * | 1993-05-27 | 1994-05-11 | 高齐崧 | The compound method of hard paralysed health |
-
2014
- 2014-03-04 CN CN201410076263.0A patent/CN103816257B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086429A (en) * | 1993-05-27 | 1994-05-11 | 高齐崧 | The compound method of hard paralysed health |
Non-Patent Citations (1)
| Title |
|---|
| 宋秀琴: "中医药治疗小儿麻痹症概况", 《辽宁中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343458A (en) * | 2015-11-25 | 2016-02-24 | 苏吉永 | Traditional Chinese medicine for treating poliomyelitis with syndrome of pathogen invading lung-defense phase |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103816257B (en) | 2015-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
| CN103393966B (en) | A kind of Chinese medicine composition for the treatment of menoxenia | |
| CN103800788A (en) | Traditional Chinese medicine preparation for treating infantile enuresis | |
| CN104547666A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN103316305A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103845429A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN103816257B (en) | A kind of Chinese medicine preparation for the treatment of poliomyelitis | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN104069454A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103341153A (en) | Traditional Chinese medicine composition for treating raynaud disease | |
| CN103385998B (en) | Traditional Chinese medicine preparation used for treating infantile dysentery | |
| CN101829249A (en) | Traditional Chinese medicine powder for treating rheumatoid diseases | |
| CN104274603A (en) | Traditional Chinese medicine for treating leg cramps | |
| CN105617036A (en) | Traditional Chinese medicine preparation for treating cardiovascular disease and production method thereof | |
| CN109939212A (en) | A kind of Chinese materia medica preparation that treating axillary nerve injury and preparation method | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN103768368A (en) | Traditional Chinese medicine composition for treating acute epididymitis | |
| CN104306530A (en) | Traditional Chinese medicine used for treating prolapse of lumbar intervertebral disc | |
| CN104352756A (en) | Traditional Chinese medicine composition for treating hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI CHUNE Free format text: FORMER OWNER: HUANG JINGJING Effective date: 20150727 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Chune Inventor after: Gao Ning Inventor after: Liu Junhua Inventor before: Huang Jingjing |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG JINGJING TO: LI CHUNE GAO NING LIU JUNHUA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150727 Address after: 266299 Shandong city of Qingdao province Jimo City Ao road 782 No. 2 No. 15 Applicant after: Li Chune Address before: 233300 Anhui city of Bengbu Province Huang Miao Cun Nan Zhen Kuai Wuhe County Huang 1 No. 250 Applicant before: Huang Jingjing |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150916 |